“We are so proud of our team of doctors, scientists and researchers for these leading-edge efforts to find new ways of diagnosing lung cancer early,” said Ann Bishop, system administrator of oncology for Baptist Cancer Center. “This research proves our methods are effective, and our efforts are unmatched in the fight against lung cancer and disparities.”

In 2021, Baptist Cancer Center announced a multifaceted initiative called the Mid-South Miracle aimed at reducing lung cancer deaths in the Mid-South 25% by 2030. The initiative comprises seven components that will address prevention, diagnosis and treatment of lung cancer through smoking cessation, low-dose CT screening, algorithmic management of incidentally detected lung nodules, multidisciplinary decision-making and care, high-quality surgical care, high-quality pathologic evaluation, including biomarker testing, and expanded access to innovative treatment through clinical trials.


Baptist Memorial Health Care Foundation awarded a $1 million grant to Baptist Cancer Center in August 2020 to fund the incidental nodule research project.

To read the “Evaluation of Lung Cancer Risk Among Persons Undergoing Screening or Guideline-Concordant Monitoring of Lung Nodules in the Mississippi Delta” study in its entirety.

JAMA, published continuously since 1883, is an international peer-reviewed general medical journal. JAMA is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications. JAMA is the most widely circulated general medical journal in the world, with more than 290,000 recipients of the print journal, more than 1.6 million recipients of electronic tables of contents and alerts, and over 34 million annual visits to the journal's website. JAMA's reach includes a growing social media presence and vast international news media exposure. JAMA's acceptance rate is 11% of the more than 9,400 annual submissions and 4% of the more than 5,200 research manuscripts received.

Baptist Cancer Center provides world-class cancer care close to home throughout Baptist Memorial Health Care’s tristate service area of Arkansas, Mississippi and Tennessee. The center takes an interdisciplinary approach to patient care and offers treatment, research, support services, community education and the area's first genetic counseling and testing program for cancer. In addition, BCC has the Mid-South's first adult myelosuppression unit, which provides specialized care for patients who have received chemotherapy that interferes with blood cell production or stops bone marrow activity. In 2019, BCC was awarded a second $9 million research grant from the National Cancer Institute to continue building its clinical research infrastructure to expand lifesaving, leading-edge treatment across the Mid-South, including overcoming disparities in cancer care under the Minority/Underserved NCI Community Oncology Research Program, known as NCORP.

Back to HCB News

CT Homepage